• High-titer convalescent plasma associated with lower risk for death from COVID-19

    7 days ago - By Healio

    Among hospitalized patients with COVID-19 who were not on mechanical ventilation, receiving high-titer convalescent plasma was associated with a lower risk for death than receiving plasma with lower antibody levels, researchers reported.
    “In response to the coronavirus pandemic, the Mayo Clinic initiated - along with support and direction from the Biomedical Advances Research and Development Authority and the FDA - the U.S. Expanded Access Program for convalescent plasma to provide access to and assess the safety profile of this experimental therapy,” Michael J. Joyner,
    Read more ...

     

  • Top in hem/onc: Blood type and COVID-19, breast cancer risk factors

    7 days ago - By Healio

    New research contradicts previous study findings that suggest there is an association between blood type and COVID-19 severity. It was the top story in hematology/oncology last week.
    Another top story was about a study that showed certain gene sets and early-life adiposity may be linked to an increased risk for breast cancer.
    Read these and more top stories in hematology/oncology below:
    Studies contradict earlier findings on blood group and COVID-19 severity, mortality
    Previous studies have shown that individuals with blood type A may be more likely to develop COVID-19 and have poor outcomes.
    Read more ...